Initially identified as a T lymphocyte-elicited inhibitor of macrophage motility, macrophage
migration inhibitory factor (MIF) has since been found to be expressed by nearly every …

The intestinal tract of vertebrates is normally colonized with a remarkable number of
commensal microorganisms that are collectively referred to as gut microbiota. Gut microbiota …

Breast cancer is a severe problem worldwide due to an increase in mortality and prevalence
among women. Despite early diagnostic procedures as well as advanced therapies, more …

Advances in cancer immunotherapy have transformed cancer care and realized
unprecedented responses in many patients. The growing arsenal of novel therapeutics …

Cancer is the second leading cause of death worldwide and epidemiological projections
predict growing cancer mortality rates in the next decades. Cancer has a close relationship …

Purpose Ductal breast carcinoma as a heterogeneous disease has different molecular
subtypes associated with clinical prognosis and patients' survival. The role of immune …

Autophagy can function as a survival mechanism for cancer cells and therefore, its inhibition
is currently being explored as a therapy for different cancer types. For breast cancer, triple …

How cancer cells cope with high levels of replication stress during rapid proliferation is
currently unclear. Here, we show that macrophage migration inhibitory factor (MIF) is a 3'flap …

Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates T cell
function. The aim of this study was to investigate the effects of AhR ligands, 2, 3, 7, 8 …

Simple Summary The effect of vitamin D3 on the development of breast cancer (favorable,
ineffective, or even unfavorable) depends on many factors, such as age, menopausal status …